MUTAGENICITY TESTS ON PROPIVERINE HYDROCHLORIDE
スポンサーリンク
概要
- 論文の詳細を見る
1. The reverse mutation test was carried out on propiverine hydrochloride (P-4) at dose range of 5-500 μg/plate using Salmonella typbimurium strains, TA100, TA98, TA1535 and TA1537, and Escbericbia coli strain WP2uvrA. -As compared with so1vent-treated control, no significant increases were observed in the number of revertant colonies in all tester strains in both systems with and without mammalian metabolic activation (S9 Mix). 2. The chromosomal aberration test was also carried out on P-4 using cultured Chinese hamster lung cells (CHL). The cells were treated with P-4 at the doses of 5, 10, 20 and 40 μM without S9 Mix and at 62.5, 125, 250 and 500 μM with S9 Mix. No significant differences were found in the incidence of structural- and numeral-aberrations of chromosomes in both systems with and without S9 Mix. 3. These rebults indicate that P-4 has no mutagenic activity.
- 日本トキシコロジー学会の論文
- 1989-05-25
著者
-
OHUCHIDA Akinobu
Drug Safety Laboratory, Taiho Pharmaceutical Co. Ltd.
-
Ohuchida Akinobu
Drug Safetey Lab. Taiho Pharmaceutical Co. Ltd.
-
Ohuchida Akinobu
Drug Safety Laboratory Taiho Pharmaceutical Co. Ltd.
-
FURUKAWA Akemi
Drug Safety Laboratory, Taiho Pharmaceutical Co., Ltd.
-
Furukawa A
Taiho Pharmaceutical Co. Ltd. Tokushima Jpn
-
Furukawa Akemi
Drug Safety Laboratory Taiho Pharmaceutical Co. Ltd.
関連論文
- 410 THE EFFECTS OF HAPTEN DENSITY ON THE ANTIGENICITY OF BPO-PROTEIN CONJUGATES IN GUINEA PIGS
- MUTAGENICITY TESTS OF MOFEZOLAC (N-22)
- Potassium oxonate modulation of 5-fluororacil-induced myelotoxicity in colony forming assay of hematopoietic precursor cells.
- IMMUNOTOXIC EFFECT OF LOW DOSE CISPLATIN IN MICE
- Immunotoxicity Study of Cisplatin
- MUTAGENICITY TESTS ON PROPIVERINE HYDROCHLORIDE
- MUTAGENICITY TEST OF CEFODIZIME SODIUM
- The different sensibility to 5-fluorouracil in three cell lines, mouse lymphoma L5178Ytk^ cells, human lymphoblastoid TK6 and WTK-1 cells. (MUTAGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- MICRONUCLEUS TEST OF MOFEZOLAC (N-22)